VAERS 2021 Database www.vaers.hhs.gov

Main Page | All 2021 Deaths | Videos
VAERS Updated: 11/12/2021
** VAERS DATABASE Last updated: November 12, 2021**
PLEASE CHECK BACK SOON
Download the files above while you wait.







Manufacturers

Total Manufacturer
199,106MODERNA
36,710JANSSEN
5,381PFIZER\BIONTECH
2,555GLAXOSMITHKLINE BIOLOGICALS
1,469UNKNOWN MANUFACTURER
897MERCK & CO. INC.
627SEQIRUS, INC.
112DYNAVAX TECHNOLOGIES CORPORATION
91SANOFI PASTEUR
75NOVARTIS VACCINES AND DIAGNOSTICS
40EMERGENT BIOSOLUTIONS
14PAXVAX
12TEVA PHARMACEUTICALS
12PROTEIN SCIENCES CORPORATION
9PFIZER\WYETH
4BERNA BIOTECH, LTD.
4SMITHKLINE BEECHAM
3INTERCELL AG
1MEDIMMUNE VACCINES, INC.
1CSL LIMITED

COVID19 Lot Number

VAX LOT Total
2S9CL7,949
7,473
2,547
1,506
1,187
1,051
1,049
s0294561,043
866
IMM209861
816
UT7065MA766
657
579
U62828AA563
557
538
U6737AA516
515
S034636506
4F472471
458
P100253275449
444
276563436
429
418
4BH32414
MENVEO404
PP9L5362
UJ446AA337
319
306
290
271
49TM3270
R1B252M253
4F472179
933622147
C5763AA144
CW3116134
3Y7NL126
UNK114
113
ARBA141A105
104
103
96
300057A90
79
1F4EB73
R1B743M62
56
UJ090AA55
51
UH894AB46
45
UNK44
UNK42
42
EJ168638
Unknown36
35
34
32
32
26
el128424
24
A115A22
22
EN620222
21
UNK20
20
19
Z127A19
19
17
JEV18K95E15
12
111798PI12
10
A739088
No batch number8
3333324181078
6
6
TAR356
5
5
U6935AA5
UNK5
4
unknown4
3
2
55RB72
2
2
2
2
2
U7124AA2
JEV18A68E2
2
ABYB05BA1
1
1
1
1
AMVA436A1
1
1
TJ3521
A130A; VIS give1
1
U7140BB1
1
1
SP UP016AA1
1
1808P08802/ESV01
037K20A300,947
EL1284288,578
57,766
1,432

Incidents per State

State Total
82,750
CA62,821
FL38,209
TX36,512
NY34,921
PA23,646
IN23,622
IL20,597
MI19,590
OH19,426
NJ18,413
NC16,769
GA15,932
WA15,351
VA15,234
MA14,876
AZ14,206
MN12,940
MD12,656
CO11,908
WI11,425
MO10,240
TN9,685
OR8,768
KY8,437
CT8,300
SC6,700
OK6,293
AL5,692
LA5,025
IA4,825
KS4,821
UT4,637
NV4,374
NM3,967
AR3,807
ME3,161
NH3,096
NE2,918
MS2,859
ID2,785
WV2,469
HI2,459
PR2,417
MT2,414
RI2,076
DE1,868
AK1,830
VT1,734
DC1,715
ND1,388
SD1,269
WY866
GU118
VI69
AS47
MP29
MH8
XB6
FM4
QM3
XV2
XL1

ID: 1692538
Sex: F
Age:
State: FL

Vax Date: 01/01/2021
Onset Date: 01/31/2021
Rec V Date: 09/11/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 037K20A
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data: Test Date: 20210206; Test Name: COVID-19 test; Test Result: Negative ; Comments: Nasal swab

Allergies:

Symptom List: Dysphagia, Epiglottitis

Symptoms: Serum sickness potential; fever; body aches; rash; fatigue; headache; This is a spontaneous report from a contactable nurse (patient). A 49-year-old non-pregnant female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection; Lot Number: E19265; Expiration date was not reported), via an unspecified route of administration, administered in the left arm on an unspecified date in Jan2021 (with the reported time of 09:00 AM) (at the age of 49-years-old) as dose 1, single for COVID-19 immunisation. The patient has no medical history and no concomitant medication. The patient has no known allergies. No other vaccine was received by the patient in four weeks. The patient had no COVID prior vaccination. On 31Jan2021, the patient experienced serum sickness potential that was diagnosed by primary doctor, severe reaction , fever, body aches, rash, fatigue and headache. Events resulted in a doctor or other healthcare professional office/clinic visit and emergency room visit. Treatment with steroids, antibiotics and symptom management were taken as a result of the events. The patient underwent lab tests and procedures which included COVID-19 test (Nasal swab): Negative on 06Feb2021. The outcome of the events was not recovered. No follow-up attempts are possible. No further information is expected.

Other Meds:

Current Illness:

ID: 1692539
Sex: F
Age:
State: CO

Vax Date: 02/20/2021
Onset Date: 02/20/2021
Rec V Date: 09/11/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 025L20A
Dose Series: 1
Vax Route: IM
Vax Site: RA

Lab Data:

Allergies:

Symptom List: Anxiety, Dyspnoea

Symptoms: Fatigue; backache; aches in both knees; sore at injection site (left arm); tender/painful lymphnode under left armpit (site of injection); This is a spontaneous report from a non-contactable consumer (patient). A non-pregnant 71-year-old female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for Injection; Lot Number: EN5318, Expiration Date not reported) via an unspecified route of administration, administered in the left arm on 20Feb2021 10:00 (at the age of 71-years-old) as dose 2, single for COVID-19 immunisation. Medical history included asthma, eczema, interstitial cystitis, prediabetes and scallop allergy. The patient previously took nickel and experienced allergy to metals; and BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for Injection; Lot Number: EN5318, Expiration Date not reported) via an unspecified route of administration, administered in the left arm on 30Jan2021 10:00 (at the age of 71-years-old) as dose 1, single for COVID-19 immunisation. The patient received unspecified concomitant medications within two weeks of receiving BNT162B2. Prior to vaccination, the patient was not diagnosed with COVID-19; and since the vaccination, has not been tested for COVID-19. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. The patient experienced fatigue, backache, aches in both knees, sore at injection site (left arm), and tender/painful lymph node under left armpit (site of injection) on 20Feb2021 18:00. No treatment was received as a result of the events. The outcome of events was recovered on an unspecified date. No follow-up attempts are possible. No further information is expected.

Other Meds:

Current Illness:

ID: 1692540
Sex: F
Age:
State:

Vax Date: 02/24/2021
Onset Date: 02/24/2021
Rec V Date: 09/11/2021
Hospital:

Vax Type: COVID19
Manufacturer: PFIZER\BIONTECH
Vax Name: COVID19 (COVID19 (PFIZER-BIONTECH))
Lot: EL1284
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Chest discomfort, Dysphagia, Pain in extremity, Visual impairment

Symptoms: chills all day; I've had vomit; nausea; high fever; This is a spontaneous report from a contactable consumer (patient). A female patient of an unspecified age (Age: 37; Unit: Unknown) received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection), via an unspecified route of administration on 24Feb2021 (Batch/Lot number was not reported) as dose 2, single for COVID-19 immunisation. The patient's medical history and concomitant medications were not reported. The patient previously took the first dose of BNT162B2 on an unspecified date for COVID-19 immunisation. On 24Feb2021, the patient experienced chills all day, since then I've had vomit, nausea, chills and high fever. The outcome of the events was not recovered/not resolved. No follow-up attempts are possible. Information about lot/batch number cannot be obtained. No further information is expected.

Other Meds:

Current Illness:

ID: 1692541
Sex: F
Age:
State:

Vax Date:
Onset Date:
Rec V Date: 09/11/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: unknown
Dose Series: UNK
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List: Dizziness, Fatigue, Mobility decreased

Symptoms: She stated she felt bad after the vaccine for a day; This is a spontaneous report from a non-contactable consumer (Patient herself) from a Pfizer-sponsored program Support. A female patient of an unspecified age received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, formulation: solution for injection) via an unspecified route of administration on an unspecified date (Batch/Lot number was not reported) as dose 1, single for COVID-19 immunisation. The patient's medical history was not reported. The patient's concomitant medications were not reported. The patient stated she felt bad after the vaccine for a day. She didn't feel good for a day. The patient stated both patient and her husband got their 1st dose and were part of a recording thing and it would text them how they were feeling etc. Advised not sure what app or texting app they are using would need to reach out to health department. She thinks she hit stop because now they were getting nothing. Outcome of the event was recovered. No follow-up attempts are possible. Information about lot/batch number could not be requested. No further information is expected.

Other Meds:

Current Illness:

ID: 1692542
Sex: M
Age:
State: CO

Vax Date: 02/20/2021
Onset Date: 02/01/2021
Rec V Date: 09/11/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot:
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data: Test Name: Laboratory tests; Result Unstructured Data: Test Result:normal

Allergies:

Symptom List: Injection site erythema, Injection site pruritus, Injection site swelling, Injection site warmth

Symptoms: fell in the shower, I guess maybe he was a little dizzy; fell in the shower, I guess maybe he was a little dizzy; weakness in his leg; it hurt him on the side of his cheek in his jaw; he couldn't get up and wasn't able to stand; This is a spontaneous report from a contactable consumer. This consumer reported for a male patient. A 89-year-old male patient received bnt162b2 (PFIZER BIONTECH COVID-19 MRNA VACCINE Solution for injection Lot Number EN6203) via an unspecified route of administration on 20Feb2021 13:20 as dose 2, single (age at vaccination: 89 years) for COVID-19 immunisation. Medical history included diabetes from an unknown date and unknown if ongoing. Concomitant medications included ongoing vitamin c [ascorbic acid] (VITAMIN C [ASCORBIC ACID]) 1000 mg daily; ongoing acetylsalicylic acid (ASPIRIN (E.C.)) 81, three times a week; ongoing nicotinamide (VITAMIN B3) 2000 units; ongoing dutasteride (DUTASTERIDE); ongoing gabapentin (GABAPENTIN) 100mg two times a daily; ongoing lisinopril (LISINOPRIL) 2.5mg daily; ongoing fish oil, tocopherol (OMEGA 3 [FISH OIL;TOCOPHEROL]) 1200mg twice a day; ongoing repaglinide (REPAGLINIDE) one half mg at breakfast; ongoing atorvastatin calcium (LIPITOR [ATORVASTATIN CALCIUM]) 10mg, daily; ongoing cyanocobalamin (VITAMIN B12 [CYANOCOBALAMIN]), all taken for an unspecified indication from an unspecified start date and ongoing. Historical vaccine included bnt162b2 (PFIZER BIONTECH COVID-19 MRNA VACCINE Solution for injection Lot Number was not reported) via an unspecified route of administration on an unspecified date as dose 1, single for COVID-19 immunisation and felt a little tired. On an unspecified date Feb2021, it was reported that my husband and I had second shot of vaccine on Saturday, we were fine on Saturday with no reaction at all and on Sunday morning, my husband fell in the shower, I guess maybe he was a little dizzy from the vaccine and then he was fine on Monday, then he had weakness in his leg, he was 89 and last night it did not hurt him not in his shoulder and or arm anymore but it hurt him on the side of his cheek in his jaw, and then he could not get up he was not able to stand. This morning he was able to get out the bed and stand now he feels better that he did yesterday, but I wanted to know, I know it were about joints this can happened about few days, but I wanted to know does it would be common for him to feel like it hurts him on one side of his mouth, will that be an side effect as well. I washed his mouth with water. Now what are going to check on that and find out. We did not had anything last week except a little tired, 3 weeks ago for the first one and I am m perfectly fine I feel chilled like for 2 hours and thats all, but he was much better today but I want to make sure I read the book that they gave me, and I want to make sure that it was just a side effect and that he will get better. The only problem was that he had weakness and could not stand up on his legs and he had pain in his cheeks. I dont know if I had to take him to the dentist and I need to find out if this is a side effect. The patient underwent lab tests and procedures which included laboratory test resulted as normal o an unspecified date. The clinical outcome of the events was not resolved. Follow-up attempts are completed. No further information is expected.

Other Meds: VITAMIN C [ASCORBIC ACID]; ASPIRIN (E.C.); VITAMIN B3; DUTASTERIDE; GABAPENTIN; LISINOPRIL; OMEGA 3 [FISH OIL;TOCOPHEROL]; REPAGLINIDE; LIPITOR [ATORVASTATIN CALCIUM]; VITAMIN B12 [CYANOCOBALAMIN]

Current Illness:

ID: 1692543
Sex: F
Age:
State: PA

Vax Date: 02/26/2021
Onset Date:
Rec V Date: 09/11/2021
Hospital:

Vax Type: FLUC4
Manufacturer: SEQIRUS, INC.
Vax Name: INFLUENZA (SEASONAL) (FLUCELVAX QUADRIVALENT)
Lot: 276563
Dose Series: 1
Vax Route: SYR
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Chills, Confusional state, Eye inflammation, Headache, Laboratory test

Symptoms: Dryness of eyes; Black prints on eyes; This is a spontaneous report from a contactable consumer. A 61-year-old female patient received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE), via an unspecified route of administration on 26Feb2021 06:15 (at the age of 61-year-old) (Batch/Lot number was not reported) as dose number unknown, single for covid-19 immunisation. Medical history included multiple issues following severe accident and known allergies: rubber. The patient's concomitant medications were not reported. The patient received any other medications within 2 weeks of vaccination but do know what. On an unspecified date, the patient experienced dryness of eyes and black prints on eyes. Prior to vaccination, the patient was not diagnosed with COVID-19 and since the vaccination, the patient had not been tested for covid-19. Outcome of events was not recovered. No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.

Other Meds:

Current Illness:

ID: 1692544
Sex: F
Age:
State: TX

Vax Date: 02/23/2021
Onset Date: 02/25/2021
Rec V Date: 09/11/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 011J20A
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Pyrexia, White blood cell count decreased

Symptoms: Bitter metallic taste; Tiredness; head pressure; flushing; muscle aches; injection site tenderness; This is a spontaneous report from a contactable nurse (patient). A 32-year-old female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection), via an unspecified route of administration, administered in right arm on 23Feb2021 08:30 (Batch/Lot Number: EN5318) (at the age of 32-years-old) as dose 2, single for COVID-19 immunisation. Medical history included allergies in latex and adhesives. The patient was not diagnosed with COVID-19 prior to vaccination and had not been tested for COVID-19 post vaccination. The patient was not pregnant at time of vaccination. Concomitant medications included levothyroxine sodium (SYNTHROID, 25 ug) taken for an unspecified indication, start and stop dates were not reported. The patient did not receive any other vaccines within 4 weeks before vaccination. The patient previously received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE) (Batch/Lot Number: EL9265) (at the age of 32-years-old) on 29Jan2021 at 09:00 for COVID-19 immunisation. The patient experienced bitter metallic taste, tiredness, head pressure, flushing, muscle aches and injection site tenderness (for 48 hours) on 25Feb2021 at 12:00, 48 hours post vaccine. The patient received no treatment for the events. The adverse events resulted to none. The outcome of events bitter metallic taste, tiredness, head pressure, flushing, muscle aches was recovering; while outcome of event injection site tenderness was recovered on 27May2021 at 12:00 (48 hours). No follow-up attempts are possible. No further information is expected.

Other Meds: SYNTHROID

Current Illness:

ID: 1692545
Sex: F
Age:
State: TN

Vax Date: 02/23/2021
Onset Date: 02/24/2021
Rec V Date: 09/11/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot:
Dose Series: UNK
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Pharyngeal swelling

Symptoms: red rash; Soreness; swelling; itching; This is a spontaneous report from a contactable consumer (patient). A female patient of an unspecified age (reported as 77, unit unknown) received BNT162B2 (Pfizer-BioNTech COVID-19 vaccine), via an unspecified route of administration, administered in the left arm on 23Feb2021 at 10:00 (Lot Number: EL9266) as dose 1, single for COVID-19 immunization. Medical history included sinus infection on an unknown date. The patient was taking unspecified concomitant medications. The patient did not receive other vaccines in four weeks. The patient previously took codeine and experienced allergy. On 24Feb2021 at 08:00 the patient experienced soreness, swelling, red rash and itching. The patient did not receive treatment for the events. The outcome of the events was recovering. No follow up attempts are possible. No further information is expected.

Other Meds:

Current Illness:

ID: 1692546
Sex: F
Age:
State: NY

Vax Date: 02/25/2021
Onset Date: 02/25/2021
Rec V Date: 09/11/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot:
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Abdominal pain, Chills, Sleep disorder

Symptoms: left arm is burning; overall body aches; Chills; Fever; Nausea; Sneezing; This is a spontaneous report from a contactable consumer (patient) via Regulatory Authority. A 27-year-old female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE) via an unspecified route of administration, administered in Arm Left on 25Feb2021 08:30 (lot number: EL9266; expiry date: unknown) at the age of 27-years-old, as dose 1, single, for Covid-19 immunisation. The patient's medical history was not reported. The patient had no known allergies. Concomitant medication included medical marijuana. The patient was not pregnant at the time of vaccination. The vaccine was administered in the hospital. The patient was not diagnosed with COVID prior vaccination. The patient did not receive other vaccines within four weeks prior to COVID vaccination. The patient has not been tested for COVID-19 since vaccination. On 25Feb2021, at 21:00, the patient's left arm was burning, experienced overall body aches, chills, fever, nausea, and sneezing. The patient did not receive treatment for the events. Outcome of the events was not recovered. No follow up attempts are possible. No further information is expected.

Other Meds: MARIJUANA

Current Illness:

ID: 1692547
Sex: F
Age:
State: CA

Vax Date: 02/10/2021
Onset Date: 02/21/2021
Rec V Date: 09/11/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 011J201A
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Diarrhoea, Nasal congestion

Symptoms: sore throat; chills; headache; fatigue; bruise and bump at injection site; bruise and bump at injection site; This is a spontaneous report from a contactable consumer (patient) received via COVID-19 Vaccine Adverse Event Reporting System (COVAES). A 70-year-old female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Solution for injection, Lot Number: EN5318), via an unspecified route of administration, administered in the left arm on 10Feb2021, at 12:15 (at the age of 70 years old) as dose 1, single for COVID-19 immunisation. Medical history included known allergies: sulfa drugs, contrast dye, and bee venom. She was not pregnant at the time of report. The patient's concomitant medications were not reported. The patient did not receive any other vaccines prior to the COVID vaccine. On 21Feb2021, 12 days after injection (as reported), the patient got sore throat, chills, headache, fatigue, and bruise and bump at injection site. The patient was not diagnosed with COVID-19 prior to vaccination and she has not been tested for COVID-19 since the vaccination. At the time of report, the patient has not recovered form the events. No follow-up attempts are possible. No further information is expected.

Other Meds:

Current Illness:

ID: 1692548
Sex: F
Age:
State: CA

Vax Date: 02/25/2021
Onset Date: 02/25/2021
Rec V Date: 09/11/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot:
Dose Series: 1
Vax Route: SYR
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Vaccination site erythema, Vaccination site pruritus, Vaccination site swelling

Symptoms: Left armpit aching; left breast started aching; Shoulder ache; Lymph node tender on left side; This is a spontaneous report from a contactable consumer (patient). A non-pregnant 67-year-old female patient received BNT162B2 (PFIZER-BIOTECH COVID-19 VACCINE, solution for injection), via an unspecified route of administration, administered in arm left on 25Feb2021 13:15 (at the age of 67 years old) as dose 2, single for COVID-19 immunisation. The patient previously received BNT162B2 (PFIZER-BIOTECH COVID-19 VACCINE, solution for injection) via an unspecified route of administration, administered on arm left on 04Feb2021 13:00 (at the age of 67 years old) as dose 1, single for COVID-19 immunisation. Medical history included sulfa drugs allergy and breast lift and implants (silicone gel implant, May2010). Concomitant medications were not reported. On 25Feb2021 20:00, the patient experienced left armpit aching, left breast started aching, shoulder ache, and lymph node tender on left side. It was reported that the injection site was fine. The facility type vaccine was reported as other. There was no other vaccine in four weeks. Prior to COVID, patient had no vaccination and not COVID tested post vaccination. There was no treatment for the adverse events. The outcome the events was not recovered. The lot number for BNT162B2, was not provided and will be requested during follow up.

Other Meds:

Current Illness:

ID: 1692549
Sex: F
Age:
State: TN

Vax Date: 12/19/2020
Onset Date: 01/07/2021
Rec V Date: 09/11/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 039k20a
Dose Series: 1
Vax Route: SYR
Vax Site: RA

Lab Data:

Allergies:

Symptom List: Rash, Urticaria

Symptoms: Swelling in face and throat; Swelling in face and throat; Laryngitis; Widespread pain; This is a spontaneous report from a contactable healthcare professional (patient) received via Regulatory Authority. A 41-year-old female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Solution for injection), via an unspecified route of administration, administered in right arm, on 19Dec2020 at 05:15 PM (Batch/Lot Number: Ej1685) (at the age of 41 years old) as dose 1, single for COVID-19 immunisation in a hospital. Medical history included chronic allergies and endometriosis. The patient was not diagnosed with COVID-19 prior to vaccination and has not been tested for COVID-19 since the vaccination. The patient was not pregnant at the time of vaccination. Concomitant medications included omalizumab (XOLAIR); montelukast sodium (SINGULAIR); cetirizine hydrochloride (ZYRTEC); duloxetine hydrochloride (CYMBALTA); vitamin B complex; lansoprazole (PREVACID). The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. The patient experienced swelling in face and throat, laryngitis, and widespread pain on 07Jan2021. The events resulted to physician office visit. The patient received prednisone as treatment for the events. The patient did not recover from the events on the time of the report. The patient was administered the second dose of BNT162B2 on 09Jan2021, single (at the age of 41-years-old) (Batch/Lot Number: Ej1686) in the right arm for COVID-19 immunisation in a hospital. No follow-up attempts are needed. No further information is expected.

Other Meds: XOLAIR; SINGULAIR; ZYRTEC [CETIRIZINE HYDROCHLORIDE]; CYMBALTA; B COMPLEX [VITAMIN B COMPLEX]; PREVACID

Current Illness:

ID: 1692550
Sex: F
Age:
State: NY

Vax Date: 02/07/2021
Onset Date: 02/07/2021
Rec V Date: 09/11/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot:
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Blood pressure decreased, Chest pain, Chills, Confusional state, Decreased appetite

Symptoms: tongue swelled in her throat, deep in her throat; throat swelled/swelling throat on the right side; swelling of her throat and tongue/ dealt with this reaction in the past; her tongue is paralyzed; The initial safety information received was reporting only non-serious adverse drug reactions. Upon receipt of follow-up information on 02Sep2021, this case now contains serious adverse reaction. Information processed together. This is a spontaneous report from a contactable consumer (patient) and from a Pfizer-sponsored program. A 71-year-old female patient received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE), dose 1 via an unspecified route of administration on 07Feb2021 (Lot Number: EM9809) as single dose (at the age of 71-years-old) for COVID-19 immunization. Medical history included angioedema, she does have allergies to some medications. She says they are just simple things like Aspirin, NSAIDs don't ever take them want more, allergic IVP dye, allergy to corn, and 'swelling of throat and tongue'. There were no concomitant medications. The patient previously took aspirin (e.c.) and experienced allergy, and Epipen. The patient experienced her tongue is paralyzed on 2021, tongue swelled in her throat, deep in her throat on 07Feb2021, and throat swelled/swelling throat on the right side on 07Feb2021. Patient received Pfizer-BioNTech COVID-19 Vaccine first dose on 07Feb2021, experienced 'swelling of her throat and tongue' within 30 minutes of getting vaccinated. She stated 'I dealt with this reaction in the past and haven't had it in like maybe... 15 years.. I used to carry an EpiPen. I think it was because it was snowing. My Allergist said if I could swallow something to gargle with antihistamines, but I had fear to do that and I didn't.' She further reported that her throat swelled and her tongue swelling in her throat, like deep in her throat. She continued to have that problem during the night. That is something she deals with she has suffered from angioedema, her doctor said, she is not sure whether or not should take the second dose. She is sorry she did do this before. She confirms she got the first dose 07Feb2021 and the throat swelling began the same day about 15 minutes after the dose was given (as reported, also reported as 30 minutes). She says it has resolved, she had it through the night but she was able to sleep so she probably felt it until about midnight that night and then it was resolved. She confirms it has resolved completely (as reported). Patient was advised not to receive the 2nd dose yet. She has been calling because of her side effects since then. She said that she had reported this condition to VSAFE and asked if there is a way to follow up. She is still experiencing a swelling throat on the right side and her tongue is paralyzed. Patient is asking if she can undergo a treatment and proceed with the 2nd dose of our COVID-19 vaccine. The final outcome of the event, tongue swelled in her throat, deep in her throat was recovered on an unspecified date, while for the rest of the events was not recovered. The event "her tongue is paralyzed" is serious (medically significant).

Other Meds:

Current Illness:

ID: 1692551
Sex: F
Age:
State:

Vax Date: 02/01/2021
Onset Date:
Rec V Date: 09/11/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 025J20-2A
Dose Series: 1
Vax Route: SYR
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Dyspnoea, Fatigue, Feeling abnormal, Head discomfort, Headache

Symptoms: injection site was hard and swollen; injection site was hard and swollen; headache; nausea; This is a spontaneous report from a contactable consumer (patient) received via Medical Information Team. A 52 (unit not specified) female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection; Lot number and Expiration date: not reported) via an unspecified route of administration on an unspecified date in Feb2021 as dose 1, single for COVID-19 immunisation. The patient was immunocompromised (taking an immunosuppressant). Concomitant medication included an unspecified immunosuppressant. On an unspecified date in 2021, the patient reported that the injection site was hard and swollen (described as "size of a quarter and looks like a huge hive"), headache, and nausea. The patient was concerned as the events has lasted over a week and the patient was taking an immunosuppressant. The outcome of the reported events was unknown. No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.

Other Meds:

Current Illness:

ID: 1692552
Sex: M
Age:
State: CA

Vax Date: 02/25/2021
Onset Date: 02/26/2021
Rec V Date: 09/11/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 011J20A
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Heart rate decreased, Heart rate increased, Hypertension, Injection site pain, Musculoskeletal chest pain

Symptoms: Swollen arm; flushed face; headache; chills; fever; arm hurt to touch or sleep on; tired; shaking; This is a spontaneous report from a non-contactable consumer (patient). A 75-year-old male patient received bnt162b2 (BNT162B2), via an unspecified route of administration, administered in Right arm on 25Feb2021 10:00, at the age of 75-years-old, (Batch/Lot Number: EN6203) as DOSE 1, SINGLE for covid-19 immunisation. Medical history included High cholesterol, drug allergy (cannot take statins due to side effect). There were no concomitant medications. The patient did not have COVID-19 prior the vaccination. On 26Feb2021 02:00, the patient experienced swollen arm, flushed face, headache, chills, fever, arm hurt to touch or sleep on, tired, and shaking. The patient was not tested for COVID-19 post vaccination. The outcome of the events was recovering. No treatment was received for the events. No follow-up attempts are possible. No further information is expected.

Other Meds:

Current Illness:

ID: 1692553
Sex: M
Age:
State: NY

Vax Date: 02/09/2021
Onset Date: 02/17/2021
Rec V Date: 09/11/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 025J20A
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data: Test Date: 20210218; Test Name: Nasal Swab; Test Result: Negative

Allergies:

Symptom List: Nausea, Pain, Pain in extremity, Paraesthesia oral, Pyrexia

Symptoms: dehydration; increased serum creatinine level; Fever; Vomiting; Nusea; This is a spontaneous report from a contactable consumer (patient). A 67-year-old male patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection), via an unspecified route of administration, administered in the left arm on 09Feb2021 at 16:45 (at the age of 66-years-old) (Lot Number: EM9809) as dose 1, single for COVID-19 immunisation. Medical history included end stage renal disease and S/P Renal Transplant. The patient has no known allergies. The patient did not receive other vaccine in four weeks. Other medications were received in two weeks. The patient did not have COVID prior to vaccination and had been tested for COVID post-vaccination. On 17Feb2021 at 08:00, the patient experienced nausea, vomiting, fever, dehydration, and increased serum creatinine level. Treatment was received for the events. Events resulted in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. The patient underwent lab tests and procedures which included SARS-CoV-2 test: negative on 18Feb2021. The outcome of the events was recovering/resolving. No follow-up attempts are possible. No further information is expected.

Other Meds:

Current Illness:

ID: 1692554
Sex: F
Age:
State: WI

Vax Date: 02/25/2021
Onset Date: 02/26/2021
Rec V Date: 09/11/2021
Hospital:

Vax Type: DTAPHEPBIP
Manufacturer: GLAXOSMITHKLINE BIOLOGICALS
Vax Name: DTAP + HEPB + IPV (PEDIARIX)
Lot:
Dose Series: UNK
Vax Route:
Vax Site: LG

Lab Data: Test Date: 20210226; Test Name: Temp; Result Unstructured Data: Test Result:101; Comments: Fever, temp of 101

Allergies:

Symptom List: SARS-CoV-2 antibody test, SARS-CoV-2 test negative

Symptoms: Chills; Headache that felt like my head was going to explode.; Fever, temp of 101; severe joint and muscle pain; severe joint and muscle pain; This is a spontaneous report from a contactable consumer (patient). An 80-year-old non-pregnant female patient received bnt162b2 (BNT162B2, Lot Number: EN6202), dose 2 via an unspecified route of administration, administered in left arm on 25Feb2021 16:00 (at the age of 80-year-old) as dose 2, single for COVID-19 immunization. Medical history included CAD (Coronary artery disease), GERD, inflammatory arthritis, allergies to penicillin and sulfa, and Covid-19. Concomitant medications included lisinopril (ZESTRIL); carvedilol; estradiol; pantoprazole. The patient previously received the first dose bnt162b2 administered in left arm on 04Feb2021 02:30 PM (Lot number: EL9264) as single dose for COVID-19 immunization. No other vaccine in four weeks. On 26Feb2021 at 05:00 AM, the patient experienced chills, fever, temp of 101, severe joint and muscle pain, headache that felt like my head was going to explode. The patient received no treatment for the events. The outcome of the events was not recovered. No follow-up attempts are possible. No further information is expected.

Other Meds: ZESTRIL; CARVEDILOL; ESTRADIOL; PANTOPRAZOLE

Current Illness:

ID: 1692555
Sex: F
Age:
State: GA

Vax Date: 01/14/2021
Onset Date: 01/14/2021
Rec V Date: 09/11/2021
Hospital:

Vax Type: HIBV
Manufacturer: MERCK & CO. INC.
Vax Name: HIB (PEDVAXHIB)
Lot:
Dose Series: UNK
Vax Route:
Vax Site: LG

Lab Data:

Allergies:

Symptom List: Ear pain, Hypoaesthesia

Symptoms: extreme nausea; heavy chest; Vasovagal reaction; extreme dizziness; This is a spontaneous report from a contactable pharmacist. An adult female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection), via an unspecified route of administration on 14Jan2021 (Batch/Lot number was not reported) as dose 1, single for COVID-19 immunisation. The patient's medical history and concomitant medications were not reported. It was unknown if the patient received other vaccines within 4 weeks before vaccination. The patient experienced extreme nausea, heavy chest, vasovagal reaction and extreme dizziness without being able to recover for 30 minutes (laying down for 30min not able to stand without extreme dizziness and heavy chest) to continue normal activities of work on 14Jan2021, 4 hours after the vaccination. The adverse events resulted to none. The outcome of events was recovered on 14Jan2021. No follow-up attempts are possible, information about lot/batch number cannot be obtained. No further information is expected.

Other Meds:

Current Illness:

ID: 1692556
Sex: U
Age:
State: PA

Vax Date: 02/23/2021
Onset Date: 02/24/2021
Rec V Date: 09/11/2021
Hospital:

Vax Type: PNC13
Manufacturer: PFIZER\WYETH
Vax Name: PNEUMO (PREVNAR13)
Lot:
Dose Series: UNK
Vax Route:
Vax Site: LG

Lab Data:

Allergies:

Symptom List: Abdominal pain upper, Dizziness, Dysgeusia

Symptoms: Maybe taste affected; Chills; Pain in joints and muscle; Pain in joints and muscle; Eyes aching; This is a spontaneous report from a Contactable (patient). A 69-year-old patient of an unspecified gender received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE), via an unspecified route of administration, administered in Arm Left on 23Feb2021 10:15 (Batch/Lot Number: EL9269) (at the age of 69 years) as dose number unknown, single for covid-19 immunisation. Medical history included major anxiety and depression, aortic valve regurgitation, bladder disorder (taking Botox for bladder problems), multiple sclerosis, hypersensitivity, all from an unknown date and unknown if ongoing. No other vaccine in four weeks. Concomitant medications included fluoxetine; duloxetine; trazodone; pantoprazole; metformin hydrochloride (METFO); all taken for an unspecified indication, start and stop date were not reported. The patient experienced maybe taste affected, chills, pain in joints and muscle, eyes aching, all on 24Feb2021 with outcome of not recovered. It was unknown if treatment was received for events. No COVID prior vaccination and patient was not tested for COVID post vaccination. No follow-up attempts are possible. No further information is expected.

Other Meds: FLUOXETINE; DULOXETINE; TRAZODONE; PANTOPRAZOLE; METFO

Current Illness:

ID: 1692557
Sex: F
Age:
State: MD

Vax Date: 02/15/2021
Onset Date: 02/15/2021
Rec V Date: 09/11/2021
Hospital:

Vax Type: RV1
Manufacturer: GLAXOSMITHKLINE BIOLOGICALS
Vax Name: ROTAVIRUS (ROTARIX)
Lot:
Dose Series: 1
Vax Route: PO
Vax Site: MO

Lab Data: Test Date: 20210215; Test Name: fever; Result Unstructured Data: Test Result:

Allergies:

Symptom List: Blood pressure increased, Chest discomfort, Heart rate increased

Symptoms: Twelve hours after the vaccine, I developed chills.; fever that went up to 100.4; Headache upon waking; aches; sore arm; This is a spontaneous report from a contactable consumer (patient) via Covid-19 Adverse Event Self-Reporting Solution . A 35-year-old female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE) via an unspecified route of administration, administered in Arm Left on 15Feb2021 09:30 (lot number: EM9810; expiry date: unknown) as dose 2, single, for Covid-19 immunisation. Medical history included intracranial hypertension with papilladema, digestive issues from removed gallbladder, and Covid-19 on an unknown date (prior vaccination). The patient had no known allergies. Concomitant medications included acetazolamide, colestipol hydrochloride, and esomeprazole magnesium taken for unspecified indications, start and stop dates were not reported. The patient previously received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE) on 25Jan2021 (lot number: EL1283; expiry date: unknown) at 11:15 AM in left arm for Covid-19 immunisation. The patient was not pregnant at the time of vaccination. The patient did not receive other vaccines within four weeks prior to COVID vaccination. The patient has not been tested for COVID-19 since vaccination. On 15Feb2021, twelve hours after the vaccine (at 21:30), the patient developed chills. Through the night she developed a fever that went up to 100.4. Headache upon waking. Chills, aches, sore arm, and fever throughout the day. Fever broke around 36 hours and then she was fine at 48 hours post vaccine. The patient did not receive treatment for the events. Outcome of the events was recovered on unspecified date. No follow-up attempts are possible; information about lot/batch number cannot been obtained. No further information expected.

Other Meds: ACETAZOLAMIDE; COLESTIPOL HYDROCHLORIDE; ESOMEPRAZOLE MAGNESIUM

Current Illness:

ID: 1692558
Sex: F
Age:
State: TX

Vax Date: 02/25/2021
Onset Date: 02/26/2021
Rec V Date: 09/11/2021
Hospital:

Vax Type: COVID19
Manufacturer: PFIZER\BIONTECH
Vax Name: COVID19 (COVID19 (PFIZER-BIONTECH))
Lot: Eh9899
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Injection site erythema, Injection site pruritus, Injection site swelling, Lymph node pain, Lymphadenopathy

Symptoms: chills; fever; muscle pain; nausea; stomach pain; tiredness/fatigue; This is a spontaneous report from a contactable consumer (patient) received via COVID-19 Vaccine Adverse Event Reporting System. A 61-year-old female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Solution for injection, Lot Number: 59267-1000-02/EN6202), via an unspecified route of administration, administered in the left arm on 25Feb2021, at 15:15 (at the age of 61 years old) as dose 1, single for COVID-19 immunisation. Medical history included heart/ atrial tachycardia and known allergies: sufa (as reported). She was not pregnant at the time of report. Concomitant medications included sotalol (reported as sotalo6) 40 mg and 80 mg, pantoprazole, and aspirin. She did not receive any other vaccines prior to the COVID vaccine. The patient previously took magnesium and experienced allergies. On 26Feb2021, at 11:00, the patient experienced chills, fever, muscle pain, nausea, stomach pain, and tiredness/fatigue. The patient was not diagnosed with COVID-19 prior to vaccination and she has not been tested for COVID-19 since the vaccination. No therapeutic measures were taken as a result of the events. At the time of report, the patient has not recovered from the events. No follow up attempts are possible. No further information is expected.

Other Meds: SOTALOL; PANTOPRAZOLE; ASPIRIN [ACETYLSALICYLIC ACID]

Current Illness:

ID: 1692559
Sex: M
Age:
State: NJ

Vax Date: 02/24/2021
Onset Date: 02/26/2021
Rec V Date: 09/11/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot:
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Unevaluable event

Symptoms: High fever; Trouble catching my breath; Shaking; Body aches; This is a spontaneous report from a contactable consumer (patient). A 30-year-old male patient received BNT162B2 (PFIZER-BIOTECH COVID-19 VACCINE, solution for injection, Batch/Lot Number: EN6203) via an unspecified route of administration, administered in arm left on 24Feb2021 18:00 (at the age of 30 years old) as dose 1, single for COVID-19 immunisation. Medical history included high blood pressure. Concomitant medications included alprazolam (XANAX) and blood pressure (as reported). Allergies to medications, food, or other products was reported to none. On 26Feb2021 19:30, the patient experienced high fever, trouble catching breath, shaking, and body aches. There was no other vaccine in four weeks. No COVID prior vaccination and not COVID tested post vaccination. There was no treatment for the events. The outcome of the event was recovering. No follow up attempts are possible. No further information is expected.

Other Meds: XANAX

Current Illness:

ID: 1692560
Sex: F
Age:
State: MD

Vax Date: 02/25/2021
Onset Date: 02/25/2021
Rec V Date: 09/11/2021
Hospital:

Vax Type: COVID19
Manufacturer: PFIZER\BIONTECH
Vax Name: COVID19 (COVID19 (PFIZER-BIONTECH))
Lot:
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Chills, Dizziness, Injection site pain, Myalgia, Pyrexia

Symptoms: Fever; chills; diarrhea; nausea; body aches; exhaustion; This is a spontaneous report from a contactable consumer (patient) received via COVAES. A 42-year-old female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Solution for injection), via an unspecified route of administration, administered in left arm, on 25Feb2021 at 08:15 AM (Batch/Lot Number: En6200) (at the age of 42 years old) as dose 2, single for COVID-19 immunisation in a clinic. Medical history included Hashimotos and lyme. The patient was not diagnosed with COVID-19 prior to vaccination and has not been tested for COVID-19 since the vaccination. The patient was not pregnant at the time of vaccination. Concomitant medications included oxcarbazepine (TRILEPTAL); sertraline hydrochloride (ZOLOFT); levothyroxine; mirtazapine. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. The patient was previously administered the first dose of BNT162B2 on 28Jan2021 at 01:30 PM (at the age of 42-years-old) (Batch/Lot number: El9263) in the right arm for COVID-19 immunisation. The patient previously took lamotrigine (LAMICTAL); topiramate (TOPAMAX) (reported as topi max); carbamazepine; oxycodone hydrochloride, oxycodone terephthalate, paracetamol (PERCOCET) and experienced allergies. The patient experienced fever, chills, diarrhea, nausea, body aches, and exhaustion on 25Feb2021 at 07:00 PM. The events were reported as non-serious. The patient did not receive any treatment for the events. The patient was recovering from the events on the time of the report. No follow-up attempts are needed. No further information is expected.

Other Meds: TRILEPTAL; ZOLOFT; LEVOTHYROXINE; MIRTAZAPINE

Current Illness:

ID: 1692561
Sex: M
Age:
State: FL

Vax Date: 02/20/2021
Onset Date: 02/21/2021
Rec V Date: 09/11/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 011L20A
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Injection site pain, Pain

Symptoms: My right hand is swollen and my wrist hurts; My right hand is swollen and my wrist hurts; This is a spontaneous report from two contactable consumers (patient and patient's wife). These consumers reported similar events for two patients. This is the first of two reports. An 85-year-old male patient received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE), via an unspecified route of administration, administered in left arm on 20Feb2021 10:00 (Batch/Lot Number: EN6200) (at the age of 85-years-old) as DOSE 1, SINGLE for COVID-19 immunisation. Medical history was none. The patient's concomitant medications were not reported. On 21Feb2021, the patient experienced his right hand was swollen and his wrist hurts. The patient had this swollen, he never had any swelling in his body and he had this swollen hand and it was the opposite arm, it was the right and he had the shot in the left arm.Therapeutic measures were taken as a result of the events which included hand wrapped with ice pack. The outcome of the events was unknown. No follow-up attempts are possible. No further information is expected.

Other Meds:

Current Illness:

ID: 1692562
Sex: F
Age:
State: TX

Vax Date: 02/20/2021
Onset Date:
Rec V Date: 09/11/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot:
Dose Series: 1
Vax Route: SYR
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Injection site pain, Menorrhagia

Symptoms: blood on the urine; This is a spontaneous report from a Pfizer. A contactable consumer reported that a 92-year-old female patient received bnt162b2 (Pfizer Covid-19 vaccine), dose 1 via an unspecified route of administration on 20Feb2021 (Lot number was not reported) as dose 1, single for COVID-19 immunization. The patient's medical history and concomitant medications were not reported. The patient experienced blood on the urine on an unspecified date with outcome of unknown. No follow-up attempts are possible; information about lot/batch number cannot been obtained. No further information is expected.

Other Meds:

Current Illness:

ID: 1692563
Sex: M
Age:
State: NY

Vax Date: 02/18/2021
Onset Date: 02/19/2021
Rec V Date: 09/11/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 025J20A
Dose Series: 1
Vax Route: SYR
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Arthralgia, Chills, Headache, Mobility decreased, Myalgia

Symptoms: Chills; Diarrhea; hot flashes; Low grade fever; rash on the leg; Vomiting; This is a spontaneous report from a contactable consumer (patient himself) via a Pfizer-sponsored program, Covax US Support. A male patient of an unspecified age received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection; Batch/Lot number was not reported) via an unspecified route of administration, on 18Feb2021 as dose 2, single for COVID-19 immunisation. The patient's medical history and concomitant medications were not reported. Historical vaccine included BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE) as 1st dose on 28Jan2021 for COVID-19 immunisation. The patient had both of the inoculations and he was having really bad side effects and was am not sure if these are from the vaccine or not. On 19Feb2021, the day after, it was reported that the patient experienced chills, diarrhea, vomiting, hot flashes, rash on the leg and low-grade fever. The outcome of the events was unknown. No follow-up attempts are possible. Information about lot/batch number cannot be obtained.

Other Meds:

Current Illness:

ID: 1692564
Sex: F
Age:
State: MS

Vax Date: 02/25/2021
Onset Date: 02/25/2021
Rec V Date: 09/11/2021
Hospital:

Vax Type: COVID19
Manufacturer: PFIZER\BIONTECH
Vax Name: COVID19 (COVID19 (PFIZER-BIONTECH))
Lot:
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Nausea, Pain in extremity, Pyrexia

Symptoms: Red rash approximately an inch wide and 2 inches long; spread to about 3 inches wide and about 5 inches long; tender to the touch; Rash; it is itchy; Sleepy; Right arm at injection site itched; This is a spontaneous report from a contactable consumer (patient). A non-pregnant 77-year-old female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE; Lot Number: EL9269), via an unspecified route of administration in right arm, on 25Feb2021 at 01:30 PM (13:30) (at the age of 77 years), as dose 2, single, for COVID-19 immunization. The patient's medical history included being anemic due to chronic kidney disease (CKD), cancer, depression, and allergies to sulfa. The patient's concomitant medications included bupropion, valproate semisodium (DIVALPROEX), levothyroxine, and other unspecified medications. The patient previously took oxycodone and experienced allergies; first dose of BNT162B2 (Lot Number: EN5318) on 01Feb2021 at 12:30 PM (at the age of 77 years) for COVID-19 immunization (left arm); and the first dose of influenza vaccine inactivated SAG 3V (FLUAD; Lot Number: PFS 2020-21Bu) on 12Jan2021 (at the age of 76 years) for immunization. The patient was not diagnosed with COVID-19 prior vaccination. The patient did not look at site later that day. On 25Feb2021 (during the first night; also reported as Wednesday), it (right arm at injection site) itched. Then next morning (26Feb2021), the patient checked it and saw a red rash approximately an inch wide and 2 inches long. The day of reporting (28Feb2021; Sunday), the rash has spread to about 3 inches wide and about 5 inches long. It is tender to the touch and now it is itchy. It is still red. The patient also was sleepy on 25Feb2021 and needed to take a 1.5-hour nap. No treatment was administered for the events. The patient has not been tested for COVID-19 post vaccination. The patient had not recovered from the events. Follow-up attempts are completed. No further information is expected.

Other Meds: BUPROPION; DIVALPROEX; LEVOTHYROXINE.

Current Illness:

ID: 1692565
Sex: F
Age:
State:

Vax Date: 02/18/2021
Onset Date: 02/19/2021
Rec V Date: 09/11/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot:
Dose Series: UNK
Vax Route: IM
Vax Site: RA

Lab Data:

Allergies:

Symptom List: Chills, Fatigue, Headache, Myalgia

Symptoms: Chills; fever (38 C); weakness; muscle pain; mild diarrhea; This is a spontaneous report from a contactable consumer (patient). A 38-year-old female patient received the second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE), via an unspecified route of administration, administered in arm right on 18Feb2021 13:00 (Batch/Lot Number: EL3247) as DOSE 2, SINGLE for COVID-19 immunisation. Medical history was reported none. The patient had no allergies to medications, food, or other products. The patient was not pregnant at time of vaccination. Prior to vaccination, the patient was not diagnosed with COVID-19. Facility where the most recent COVID-19 vaccine was administered in workplace clinic. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. Concomitant medication included calcium taken for supplement, start and stop date were not reported. The patient previously received the first dose of BNT162B2, via an unspecified route of administration, administered in arm right on 27Jan2021 12:00 (Batch/Lot Number: EL3247) as DOSE 1, SINGLE for COVID-19 immunisation. On 19Feb2021, the patient experienced chills, fever (38 C), weakness, muscle pain, mild diarrhea, lasted for one day following the vaccination. The patient started experiencing the symptoms on Friday 19Feb2021, and reported on Monday 22Feb2021, when she had no more symptoms and could conclude that the adverse effects were finished. Treatment was not received for the adverse events. The outcome of the event was recovered on unspecified date in Feb2021. Since the vaccination, the patient has not been tested for COVID-19. No follow-up attempts are needed. No further information is expected.

Other Meds: CALCIUM

Current Illness:

ID: 1692566
Sex: M
Age:
State: OH

Vax Date: 02/21/2021
Onset Date: 02/21/2021
Rec V Date: 09/11/2021
Hospital:

Vax Type: COVID19
Manufacturer: PFIZER\BIONTECH
Vax Name: COVID19 (COVID19 (PFIZER-BIONTECH))
Lot:
Dose Series: 1
Vax Route: IM
Vax Site: RA

Lab Data: Test Name: Blood tests; Result Unstructured Data: Test Result:Normal

Allergies:

Symptom List: Headache, Heart rate increased, Injection site erythema, Injection site pain, Injection site swelling

Symptoms: There was rash was all over the body/it was red in color; Little dry skin; This is a spontaneous report from a contactable physician. An 87-year-old male patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection, Batch/Lot Number: EN6201; Expiration Date: Jul2021), via an unspecified route of administration, administered in left arm (reported left shoulder) on 21Feb2021 (at 87 years old) as dose 2, single for COVID-19 immunization. Medical history included colon cancer. There were no concomitant medications. The patient previously received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Lot number: EL9261), on 30Jan2021 (at 87 years old), for COVID-19 immunization. It was reported that after the patient came home on 21Feb2021, the rash was all over the body. He wanted to know what he should do. He has little dry skin, no fever, no pain, no headache. He got the rash on Sunday, 21Feb2021, and went there, it was so cold there, that his whole body was covered, and so he did not see the rash till he went to bed at night on Monday. The was rash was all over the body, there was no temperature when touching it, it was red in color, there was no texture when looking at it, the skin appeared smooth, however his skin was a little dry. The patient underwent blood tests which were all normal on an unknown date. The outcome of the events was unknown. No follow-up attempts are possible. No further information is expected.

Other Meds:

Current Illness:

ID: 1692567
Sex: M
Age:
State: MN

Vax Date: 02/16/2021
Onset Date:
Rec V Date: 09/11/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot:
Dose Series: 1
Vax Route: IM
Vax Site: RA

Lab Data:

Allergies:

Symptom List: Nausea

Symptoms: worsened after getting the second dose/about 30 spots of pink light colored dots/pink dots that don't itch, they are not all round, they can be oblong, they are a lighter pink; This is a spontaneous report from a contactable consumer (patient). A 74-year-old male patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE Solution for injection), via an unspecified route of administration, on 16Feb2021 (Batch/lot number unknown), as dose 2, single, for COVID-19 immunisation, at a hospital. Historical vaccine included BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE Solution for injection) received on 26Jan2021 (Batch/lot number unknown), at age 74 years old, as dose 1, single, for COVID-19 immunisation, after which the patient had a little rash. The patient did not notice the rash too much after the first dose. The patient described the rash as dots a quarter inch to the size of a quarter that do not itch. He stated that since they were where his suspenders go that the skin might just be getting irritated. On an unspecified date, the rash worsened after getting the second dose. The patient described the rash as "pink dots that don't itch, they are not all round, they can be oblong, they are a lighter pink". It was located only on his chest and shoulders, was not itchy, but was about 30 spots of pink light-colored dots. The patient tried NEOSPORIN (not helpful) and Melluca oil which only made the rashes darker. The patient called a local clinic to schedule an appointment and they asked him to talk to Pfizer first to see what their recommendations were. The patient would like to know if there was anything that he could put on his rash to treat it. The outcome of the event was not recovered. No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.

Other Meds:

Current Illness:

ID: 1692568
Sex: M
Age:
State: NY

Vax Date: 01/29/2021
Onset Date: 02/27/2021
Rec V Date: 09/11/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot:
Dose Series: UNK
Vax Route: IM
Vax Site: LA

Lab Data: Test Date: 2021; Test Name: X-rays; Result Unstructured Data: Test Result:Unknown results; Test Date: 2021; Test Name: CT scan; Result Unstructured Data: Test Result:Unknown results

Allergies:

Symptom List: Injection site pain

Symptoms: unable to blink left eye and move left side of mouth. Right side face looks dissformed.; Stiffness; swelling of face; This is a spontaneous report from a contactable consumer (patient). A 68-year-old male patient received BNT162b2 (BNT162B2), via an unspecified route of administration administered in right arm on 29Jan2021 at 14:00 (Batch/Lot Number: EN5318) (at the age of 68-years-old) as dose 1, single for COVID-19 immunisation. Vaccination facility type was hospital. Medical history included previous cancers, and known allergies: shrimp. The patient has no COVID prior to vaccination and unknown if patient was tested for COVID post vaccination. Concomitant medications included lisinopril, levothyroxine sodium, atorvastatin calcium and acetylsalicylic acid (ASPRIN), all taken as of two weeks for an unspecified indications, start and stop dates were not reported. The patient previously took olmesartan medoxomil (BENICAR) and ciprofloxacin (CIPRO) and experienced allergy. The patient did not receive any other vaccine in four weeks. On 27Feb2021, the patient experienced stiffness, swelling, of face, unable to blink left eye and move left side of mouth. Right side face looks diss-formed. Treatment for the events included Prednisone and Valacyclovir. Relevant tests and procedures included X-Rays and Computerized tomography (CT) Scan on an unspecified date in 2021. The events resulted in a doctor or other healthcare professional office/clinic visit and Emergency room/department or urgent care. The outcome of the events was not recovered. No follow up attempts are possible. No further information is expected.

Other Meds: LISINOPRIL; LEVOTHYROXINE SODIUM; ATORVASTATIN CALCIUM; ASPRIN

Current Illness:

ID: 1692569
Sex: F
Age:
State: NJ

Vax Date: 02/26/2021
Onset Date: 02/28/2021
Rec V Date: 09/11/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot:
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Injection site induration, Injection site pruritus, Injection site swelling, Injection site warmth

Symptoms: arm was swollen; arm was very itchy; arm was red; arm was fevered to touch/hot to touch; This is a spontaneous report from a contactable consumer (patient). A 72-year-old female patient received BNT162B2 PFIZER-BIONTECH COVID-19 VACCINE Solution for injection), via an unspecified route of administration, administered in the left arm, on 26Feb2021 09:45 (Batch/lot number: EL9266), at age 72 years old, as dose 2, single, for COVID-19 immunisaiton, at a clinic. The patient was not pregnant at the time of vaccination. Relevant medical history included Hashimoto disease and known allergy to some band aid products both from unknown dates, not reported if ongoing or not. The patient did not have COVID-19 prior to vaccination and was not tested for COVID-19 post vaccination. Concomitant medication included levothyroxine taken for an unknown indication, start and stop dates not reported. The patient previously took bacitracin and ciprofloxacin (CIPRO) and experienced allergies to both. Historical vaccine included BNT162B2 PFIZER-BIONTECH COVID-19 VACCINE Solution for injection), administered in the left arm, on 05Feb2021 09:45 (Batch/lot number: EL9264), at age 72 years old, as dose 1, single, for COVID-19 immunisation. The patient did not have other vaccines in four weeks. On 28Feb2021 09:45, 48 hours after the second injection, the patient's arm was red, swollen, fevered to touch/hot to touch and very itchy. At the time of the report, it was still very itchy a little swollen but not hot to the touch. No treatment was given for the events. The patient recovered from "arm was fevered to touch/hot to touch" on an unspecified date and was recovering from "arm was swollen" and "arm was red". The outcome of "arm was very itchy" was not recovered. No follow-up attempts are possible. No further information is expected.

Other Meds: LEVOTHYROXINE

Current Illness:

ID: 1692570
Sex: F
Age:
State: PA

Vax Date: 02/27/2021
Onset Date: 02/28/2021
Rec V Date: 09/11/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 011j20a
Dose Series: 1
Vax Route: IM
Vax Site: RA

Lab Data: Test Date: 20210228; Test Name: body temperature; Result Unstructured Data: Test Result:100.2-101.7

Allergies:

Symptom List: Chills, Dizziness, Nausea, Pain, Tachycardia

Symptoms: Severe joint pain; Fever ranging from 100.2-101.7; This is a spontaneous report from a contactable consumer (patient) received via COVAES. A 49-year-old female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection), via an unspecified route of administration, administered in right arm on 27Feb2021 08:30 (Batch/Lot Number: EN6205) (at the age of 49-years-old) as dose 2, single for COVID-19 immunisation. Medical history included high blood pressure, asthma, history of breast cancer and allergies from peanuts, corn and tomatoes. The patient was not pregnant at time of vaccination. The patient was not diagnosed with COVID-19 prior to vaccination and had not been tested for COVID-19 since the vaccination. Concomitant medications included atenolol; omeprazole; tocopherol (VITAMIN E); and ergocalciferol (VITAMIN D); all taken for an unspecified indication, start and stop dates were not reported. The patient did not receive any other vaccines within 4 weeks prior to vaccination. The patient previously received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE) administered in right arm (Batch/Lot Number: EL9266) (at the age of 49-years-old) on 06Feb2021 at 08:30 for COVID-19 immunisation. The patient experienced severe joint pain (almost unable to sit and stand) and fever ranging from 100.2-101.7 (unit not reported) on 28Feb2021 at 11:00. The patient received no treatment for the events. The adverse events resulted to none. The outcome of event severe joint pain was recovered on 02Mar2021 at 11:00; while outcome of event fever ranging from 100.2-101.7 was recovering. No follow up attempts are possible. No further information is expected.

Other Meds: ATENOLOL; OMEPRAZOLE; VITAMIN E [TOCOPHEROL]; VITAMIN D [ERGOCALCIFEROL]

Current Illness:

ID: 1692571
Sex: M
Age:
State:

Vax Date: 02/19/2021
Onset Date: 02/19/2021
Rec V Date: 09/11/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 039K20A
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Tremor

Symptoms: double vision; throat began swelling; This is a spontaneous report from a contactable consumer (patient). A male patient (Age: 72; Unit: Unknown) received first dose of BNT162B2 (Pfizer-Biontech Covid-19 Vaccine), via an unspecified route of administration on 19Feb2021 as single dose for COVID-19 immunisation. Medical history and concomitant medications were not reported. The patient received first dose of Pfizer vaccine on 19Feb2021. Within 5 minutes of receiving the shot, his throat began swelling and it went. He also experienced double vision, time after vaccine unspecified. Patient asked if this is a reported side effect, if he can receive the second dose, and the efficacy of one dose. The outcome of the events was unknown. No follow up attempts are possible; information about lot/batch number cannot be obtained.

Other Meds:

Current Illness:

ID: 1692572
Sex: M
Age:
State: IN

Vax Date: 02/09/2021
Onset Date: 02/27/2021
Rec V Date: 09/11/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 025J20A
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Erythema, Pruritus

Symptoms: Swelling of the lips; hives on upper body; This is a spontaneous report from a contactable consumer (patient). A 72-years-old male patient received BNT162B2 (PFIZER-BIOTECH COVID-19 VACCINE, solution for injection, Batch/Lot Number: EM9810), via an unspecified route of administration on 09Feb2021 15:30 (at the age of 72 years old) as dose number unknown, single for COVID-19 immunisation. The patient medical history was reported as none and there was concomitant medication in two weeks (also reported as there was other medication in two weeks). Known allergies was reported as not sure. On 27Feb2021, the patient experienced swelling of the lips, and hives on upper body. There was no other vaccine in four weeks. The events resulted in Emergency room/department or urgent care. Patient had no COVID prior vaccination and not COVID tested post vaccination. Treatment was received on all events. The outcome of the events was not recovered. No follow-up attempts are needed. No further information is expected.

Other Meds:

Current Illness:

ID: 1692573
Sex: F
Age:
State:

Vax Date:
Onset Date:
Rec V Date: 09/11/2021
Hospital:

Vax Type: UNK
Manufacturer: UNKNOWN MANUFACTURER
Vax Name: VACCINE NOT SPECIFIED (NO BRAND NAME)
Lot:
Dose Series: UNK
Vax Route: SYR
Vax Site: UN

Lab Data:

Allergies:

Symptom List: Injection site erythema, Injection site induration, Injection site pruritus, Injection site swelling, Myalgia

Symptoms: chills; fever; sore throat; This is a spontaneous report from a contactable consumer. An 87-years-old female patient received bnt162b2 (BNT162B2), via an unspecified route of administration at the age of 87 years old on an unspecified date (Batch/Lot number was not reported) as dose number unknown, single for covid-19 immunisation. Medical history was not reported. Concomitant medication included palbociclib (IBRANCE). On an unspecified date, the patient experienced chills, fever and sore throat (believes sore throat is due to dry environment at facility). The outcome of the events was unknown. No follow-up attempts are possible; information about lot/batch number cannot be obtained.

Other Meds: IBRANCE

Current Illness:

ID: 1692574
Sex: F
Age:
State: NM

Vax Date: 02/24/2021
Onset Date: 02/26/2021
Rec V Date: 09/11/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 011J20A
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Cough, Limb discomfort, Pain, SARS-CoV-2 test positive

Symptoms: Swollen, dark red, itchy rash from shoulder to wrist of the arm; Swollen, dark red, itchy rash from shoulder to wrist of the arm; This is a spontaneous report from a contactable consumer (patient). A 76-year-old female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, lot number: EN6198), via an unspecified route of administration, administered in arm left on 24Feb2021 10:30 (at the age of 76-years-old) as dose number unknown, single for covid-19 immunisation. The patient was not pregnant at the time of vaccination. The patient medical history included sarcoidosis, eczema, vertigo and tinnitus. Concomitant medications included temazepam; lorazepam; hydroxyzine hydrochloride (HYDROXIZINE); levothyroxine sodium (LEVOXYL); and montelukast sodium (SINGULAIR); all were taken for an unspecified indication, start and stop date were not reported. On 26Feb2021 08:00 AM, the patient experienced swollen, dark red, itchy rash from shoulder to wrist of the arm where she received to shot in. No treatment was received for the reported events. The outcome of the events was not recovered. No follow-up attempts are needed. No further information is expected.

Other Meds: TEMAZEPAM; LORAZEPAM; HYDROXIZINE; LEVOXYL; SINGULAIR

Current Illness:

ID: 1692575
Sex: F
Age:
State: NY

Vax Date: 02/27/2021
Onset Date: 03/01/2021
Rec V Date: 09/11/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 039K20A
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Asthenia, Chills, Headache, Myalgia

Symptoms: cough; colds; This is a spontaneous report from a Pfizer-sponsored program. A contactable consumer (patient) reported that a female patient of an unspecified age received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE), via an unspecified route of administration on 27Feb2021 (Batch/Lot number was not reported) as dose 1, single for COVID-19 immunisation. The patient's medical history and concomitant medications were not reported. On 01Mar2021, the patient woke up with a cough and colds. She said that it could be that the vaccine was causing her cough. She reported that she had her first dose on Saturday, 27Feb2921 and said that she was fine on 28Feb2021, but on 01May2021, she woke up with a cough and colds. She asked if it was due to the vaccine. She asked if she can take guaifenesin (MUCINEX). She knows she can take Tylenol but not ibuprofen. The outcome of the events was unknown. No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.

Other Meds:

Current Illness:

ID: 1692576
Sex: F
Age:
State: MN

Vax Date: 02/05/2021
Onset Date:
Rec V Date: 09/11/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 011J20A
Dose Series: 1
Vax Route: SYR
Vax Site: LA

Lab Data: Test Date: 202102; Test Name: temperature; Result Unstructured Data: Test Result:102.5; Test Date: 202102; Test Name: Rapid Covid19 test; Result Unstructured Data: Test Result:negative

Allergies:

Symptom List: Injection site erythema, Injection site pain, Injection site swelling

Symptoms: Chills; Body aches; temperature of up to 102.5; This is a spontaneous report from a contactable consumer (patient). A 78-year-old non-pregnant female patient received bnt162b2 (BNT162B2), dose 1 at vaccination age 78-year-old via an unspecified route of administration in the right arm on 05Feb2021 03:00 (Batch/Lot number was not reported) as dose 1, single for covid-19 immunisation. The patient medical history was not reported. The patient did not have covid prior to vaccination. Concomitant medications included aspirin [acetylsalicylic acid] (ASPIRIN); simvastatin; amlodipine; carvedilol and colecalciferol (Vit D); all indication, start and stop date were not reported. The patient did not receive other vaccine in the past four weeks. On Feb2021, the patient experienced chills, body aches and temperature of up to 102.5. The patient reported that she has experienced after receiving the vaccine. She mentioned that she did not have a reaction to the first vaccine until 2 weeks later (Feb2021) she developed a temperature of up to 102.5 and had the chills and body aches. This lasted about 36 hours and she did have a Rapid Covid19 test which came back negative. The patient has not been COVID tested post vaccination. The outcome of the events was recovering. No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected

Other Meds: ASPIRIN [ACETYLSALICYLIC ACID]; SIMVASTATIN; AMLODIPINE; CARVEDILOL; VIT D [COLECALCIFEROL]

Current Illness:

ID: 1692577
Sex: M
Age:
State: CA

Vax Date: 02/22/2021
Onset Date: 02/23/2021
Rec V Date: 09/11/2021
Hospital:

Vax Type: COVID19
Manufacturer: PFIZER\BIONTECH
Vax Name: COVID19 (COVID19 (PFIZER-BIONTECH))
Lot: EK9231
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data: Test Date: 2021; Test Name: temperature; Result Unstructured Data: Test Result:right under 100

Allergies:

Symptom List: Chills, Feeling cold, Feeling hot, Myalgia, Pain

Symptoms: Shortness of breath; Headache; temperatures right under 100; Dizziness; Weakness; Joint pain; This is a spontaneous report received from a contactable consumer (patient's wife) and a consumer (patient). This consumer reported similar events for two patients. This is the second of two reports. A 67-year-old male patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection; Lot number: EN6198 and Expiration date: not reported) via an unspecified route of administration on 22Feb2021 (at the age of 67 years old) as dose 2, single for COVID-19 immunisation. The patient was diabetic (ongoing; diagnosed about 6-7 years ago). Concomitant medication was not reported. The patient previously received the 1st dose of BNT162B2 (Lot number: EL9262) on an unspecified date for COVID-19 immunisation and did not feel anything. On 23Feb2021, the patient experienced shortness of breath and a headache (for 3 or 4 days). On unspecified dates in 2021, the patient also experienced "temperatures right under 100", dizziness, weakness, and joint pain. The patient was almost brought to the hospital due to shortness of breath but decided it wasn't bad enough and the patient was just uncomfortable, and that went away. The patient has missed work all week. The outcome of the events shortness of breath was recovered on an unspecified date in Feb2021; headache, dizziness, and weakness were recovering; joint pain was not recovered; while "temperatures right under 100" was unknown. No follow-up attempts are needed. No further information is expected. Sender's Comments: Linked Report(s) : PFIZER INC-2021223797 Same reporter/product, similar events, different patient.

Other Meds:

Current Illness: Diabetic (ongoing; diagnosed about 6-7 years ago.)

ID: 1692578
Sex: M
Age:
State: AK

Vax Date: 02/16/2021
Onset Date: 02/18/2021
Rec V Date: 09/11/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot:
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Pain in extremity

Symptoms: head to feet skin rash/ decreased to patch or rash; head to feet skin rash/ decreased to patch or rash; This is a spontaneous report from a contactable consumer (patient) received via COVID-19 Vaccine Adverse Event Reporting System (COVAES). A 59-year-old male patient received BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Solution for injection, Lot Number: EN6201), via an unspecified route of administration, administered in the right arm on 16Feb2021, at 13:15 (at the age of 59 years old) as dose 1, single for COVID-19 immunisation. Medical history included PNET cancer, seizures, known allergies: sulfa drugs, etc. Concomitant medications included brivaracetam (BRIVIACT), pregabalin (LYRICA), everolimus (AFINITOR), dexamethasone, and others. He did not receive any other vaccines prior to the COVID vaccine. The patient previously took rifaximin and experienced allergies. On 18Feb2021, at 13:00, the patient got head to feet skin rash on day 3 to 8. It decreased to patch or rash on day 9 (24Feb2021) to 11. The events resulted in a doctor or other healthcare professional office/clinic visit. The patient was not diagnosed with COVID-19 prior to vaccination and he has not been tested for COVID-19 since the vaccination. Therapeutic measures were taken as a result of the events which included triamcinolone acetonide 0.1% ointment. At the time of report, the patient was still recovering from the events. No follow up attempts are possible. No further information is expected.

Other Meds: BRIVIACT; LYRICA; AFINITOR; DEXAMETHASONE

Current Illness:

ID: 1692579
Sex: F
Age:
State: AZ

Vax Date: 02/12/2021
Onset Date:
Rec V Date: 09/11/2021
Hospital:

Vax Type: COVID19
Manufacturer: PFIZER\BIONTECH
Vax Name: COVID19 (COVID19 (PFIZER-BIONTECH))
Lot:
Dose Series: 2
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List: Abdominal pain upper, Abnormal behaviour, Adverse reaction, Anger, Asthma

Symptoms: eyelids are swollen; red underneath her eyes; they are real puffy; This is a spontaneous report from a contactable consumer (patient). A female patient of an unspecified age received BNT162B2 (PFIZER-BIOTECH COVID-19 VACCINE, solution for injection) via an unspecified route of administration on 12Feb2021 as dose 1, single for COVID-19 immunisation. The patient's medical history and concomitant medications were not reported. On an unspecified date, the patient experienced eyelids are swollen, red underneath her eyes, and they are real puffy. The outcome of the events was unknown. No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.

Other Meds:

Current Illness:

ID: 1692580
Sex: F
Age:
State: GA

Vax Date: 01/20/2021
Onset Date: 01/20/2021
Rec V Date: 09/11/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 039K20A
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Consciousness fluctuating, Crying, Dry skin, Epistaxis, Headache

Symptoms: some puffy eyes; swollen eyes; This is a spontaneous report from a contactable nurse (patient). A 68-year-old female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE), via an unspecified route of administration on 20Jan2021 (Batch/Lot number was not reported; at the age of 68 years old) as dose 1, single for COVID-19 immunisation. Medical history included that she was in the hospital due to penicillin. There were no concomitant medications. The patient previously took penicillin and experienced horrible rash (10-15 years ago she was in the hospital for a week after a drug reaction to penicillin). After receiving the first dose on 20Jan2021, the patient experienced some puffy eyes and swollen eyes in the evening and the next morning on 21Jan2021. Outcome of the events was unknown. No follow-up attempts are possible; information about lot/batch number cannot be obtained.

Other Meds:

Current Illness:

ID: 1692581
Sex: F
Age:
State: NY

Vax Date:
Onset Date:
Rec V Date: 09/11/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 025J20A
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Hypotonia, Lethargy, Respiratory rate decreased, Screaming, Skin warm

Symptoms: coughed up blood; This is a spontaneous report from a contactable consumer. A female patient of an unspecified age (Age: 85, Unit: unknown) received BNT162B2 (Pfizer-BioNTech COVID-19 vaccine), via an unspecified route of administration on an unknown date in 2021 (lot number was not reported) as dose 1, single for COVID-19 immunization. The patient's medical history was not reported. Concomitant medication included aspirin [acetylsalicylic acid] (ASPIRIN) taken for an unspecified indication, start and stop date were not reported. It was reported that the patient received the first dose of the vaccine on an unknown date in 2021 and had no reaction but coughed up blood twice on an unknown date in 2021. The reporter wanted to know if this was a side effect of the vaccine. The outcome of the event was unknown. No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.

Other Meds: ASPIRIN [ACETYLSALICYLIC ACID]

Current Illness:

ID: 1692582
Sex: F
Age:
State: IL

Vax Date: 02/22/2021
Onset Date: 02/24/2021
Rec V Date: 09/11/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 026LZOA
Dose Series: 1
Vax Route: IM
Vax Site: RA

Lab Data:

Allergies:

Symptom List: Vomiting

Symptoms: knees had been in great pain; This is a spontaneous report from a contactable consumer (patient). A 55-year-old female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE Solution for injection), via an unspecified route of vaccination, administered in the left arm, on 22Feb2021 14:00 (Batch/lot number: EN6202), at age 55 years old, as dose 1, single, for COVID-19 immunisation, at a health clinic. The patient was not pregnant at the time of vaccination. Relevant medical history included joint disorder (reported as "received cortisone shots in both knees" and "weaker knee") from an unknown date, not reported if ongoing or not. The patient has no known allergies. The patient did not have COVID-19 prior to vaccination and was not tested for COVID-19 post vaccination. Concomitant medications were not reported. The patient previously received cortisone shots in both knees 3 weeks prior to vaccine in 2021 and was feeling great until 2 days after the vaccine. The patient did not receive other vaccines in four weeks. On 24Feb2021 16:45, the patient's knees had been in great pain, the weaker knee was worse than the other. The patient was not sure if she should get the second dose of the vaccine because she was afraid it may get worse. The patient did not receive treatment for the event. The outcome of the event was not resolved. No follow-up attempts are needed. No further information is expected.

Other Meds:

Current Illness:

ID: 1692583
Sex: F
Age:
State: TX

Vax Date: 02/25/2021
Onset Date: 02/26/2021
Rec V Date: 09/11/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 037K20A
Dose Series: 1
Vax Route: SYR
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Headache, Limb discomfort, Nasal congestion

Symptoms: left arm broke out in bumps and was sore; left arm broke out in bumps and was sore; This is a spontaneous report from a contactable consumer (patient). A 58-year-old female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE Solution for injection), via an unspecified route of administration, administered in the left arm, on 25Feb2021 16:00 (Batch/lot number: EN6202), at age 58 years old, as dose 1, single, for COVID-19 immunisaiton, at a pharmacy/drugstore. The patient was not pregnant at the time of vaccination. Relevant medical history included diabetes and high blood pressure both from unknown dates, not reported if ongoing or not. The patient has no known allergies. The patient did not have COVID-19 prior to vaccination and was not tested for COVID-19 post vaccination. Concomitant medication included insulin from an unknown indication, not reported if ongoing or not. The patient did not have other vaccines in four weeks. On 26Feb2021 02:00, the patient's left arm broke out in bumps and was sore. The events resulted to physician's office visit. The patient did not receive treatment for the events. The outcome of the events was resolving. No follow-up attempts are possible. No further information is expected.

Other Meds: INSULIN

Current Illness:

ID: 1692584
Sex: F
Age:
State: NC

Vax Date: 02/27/2021
Onset Date: 02/27/2021
Rec V Date: 09/11/2021
Hospital:

Vax Type: COVID19
Manufacturer: PFIZER\BIONTECH
Vax Name: COVID19 (COVID19 (PFIZER-BIONTECH))
Lot:
Dose Series: 1
Vax Route: IM
Vax Site: RA

Lab Data:

Allergies:

Symptom List: Back pain, Cold sweat, Headache, Nausea, Vomiting

Symptoms: Inflammatory response; face turned red; patient sounded as congested although the patient was not; This is a spontaneous report from a contactable consumer (patient) received via the Regulatory Authority. A 39-year-old female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Solution for injection), via an unspecified route of administration, administered in left arm, on 27Feb2021 at 01:15 PM (Batch/Lot Number: 68u6203) (at the age of 39 years old) as dose 1, single for COVID-19 immunisation. Medical history included asthma and hyperthyroidism . The patient was not diagnosed with COVID-19 prior to vaccination and has not been tested for COVID-19 since the vaccination. The patient has known allergies to sulfa and pertussis vaccine. The patient was not pregnant at the time of vaccination. The patient's concomitant medications were not reported. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. On 27Feb2021 at 04:00 PM, the patient experienced inflammatory response (also reported as within 4 hours), face turned red, and the patient sounded as congested although the patient was not. The patient has taken diphenhydramine (BENADRYL) as treatment for the events. The events went away after the patient took the medicine. The patient recovered from the events on an unspecified date in 2021. No follow-up attempts are needed. No further information is expected.

Other Meds:

Current Illness:

ID: 1692585
Sex: M
Age:
State: HI

Vax Date: 01/28/2021
Onset Date: 01/30/2021
Rec V Date: 09/11/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 025j20-2A
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data: Test Date: 20210218; Test Name: identified some water on the knee; Result Unstructured Data: Test Result:result not reported

Allergies:

Symptom List: Injection site swelling, Limb discomfort

Symptoms: soreness in the right knee; This is a spontaneous report from a contactable consumer (patient) received via COVAES. A 63-year-old male patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection; Lot number: EN5318 and Expiration date: not reported) via an unspecified route of administration, administered on the left arm on 28Jan2021 11:00 (at the age of 63 years old) as dose 1, single for COVID-19 immunisation. The patient's medical history was reported as none. The patient has no known allergies. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. The patient was not diagnosed with COVID-19 prior to vaccination nor was tested for COVID-19 since vaccination. Concomitant medications included simvastatin, ascophyllum nodosum;ascorbic acid;ascorbyl palmitate;bacopa monnieri leaf;betacarotene;biotin;boron citrate;calcium ascorbate;calcium citrate;calcium pantothenate;calcium succinate;choline bitartrate;chromium nicotinate;colecalciferol;copper citrate;copper glycinate;cyanocobalamin;deanol bitartrate;docosahexaenoic acid;electrolytes nos;folic acid;gamma-aminobutyric acid;huperzia serrata;inositol;inositol nicotinate;iron pentacarbonyl;levoglutamide;magnesium citrate;magnesium malate;magnesium taurate;manganese citrate;molybdenum amino acid chelate;n-acetyltyrosin;nicotinamide;nutrients nos;phosphatidyl serine;potassium ascorbate;potassium aspartate;potassium citrate;pyridoxal phosphate;pyridoxine oxoglurate;riboflavin;selenomethionine;sodium ascorbate;thiamine mononitrate;tocopheryl acid succinate;vaccinium myrtillus fruit;vanadyl sulfate;vinpocetine;vitis vinifera;zinc ascorbate;zinc citrate (FOCUSFACTOR), and ascorbic acid, calcium, minerals nos, retinol, tocopheryl acetate, vitamin b nos, vitamins nos, zinc (CENTRUM SILVER) taken for unspecified indications. On 30Jan2021, about 2 days following the first shot, the patient experienced soreness in the right knee that progressively got to the point that the patient couldn't apply pressure on his right leg. On 18Feb2021, the patient saw an orthopedic surgeon for an assessment and they identified some water on the knee; result not reported. The patient was given a cortisone shot. The outcome of the reported event was recovering. No follow-up attempts are needed. No further information is expected.

Other Meds: SIMVASTATIN; FOCUSFACTOR; CENTRUM SILVER [ASCORBIC ACID;CALCIUM;MINERALS NOS;RETINOL;TOCOPHERYL ACETATE;VITAMIN B NOS;VITAMINS

Current Illness:

ID: 1692586
Sex: F
Age:
State: CA

Vax Date: 12/22/2020
Onset Date: 12/23/2020
Rec V Date: 09/11/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot:
Dose Series: 1
Vax Route: IM
Vax Site: RA

Lab Data: Test Date: 20210222; Test Name: Nasal Swab; Result Unstructured Data: Test Result:unknown results; Test Date: 20210302; Test Name: Nasal Swab; Test Result: Negative

Allergies:

Symptom List: Chills, Diarrhoea, Fatigue, Feeling abnormal, Headache

Symptoms: swollen face specially cheeks; eyes was swollen; RT eye lid skin was dropping down to the point she cannot use it; Running nose; Head Ache; This is a spontaneous report from a contactable nurse. A 60-year-old female patient received BNT162B2, intramuscular, administered in left arm on 22Dec2020 12:00 (Batch/Lot Number: ELo140, also reported as EL0140) at the age of 60 years old as dose 1, single for COVID-19 immunisation. Medical history included high cholestrol. Patient was not pregnant at the time of vaccination. No allergies to medications, food, or other products. Concomitant medications were not specified but reported that received other medications within 2 weeks of vaccination. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. On 23Dec2020 04:00 (the next day after she took the vaccination), the patient had running nose that lasts one day and experienced head ache for three days (as reported) which patient took acetaminophen (TYLENOL) for a relief. Then on 27Dec2020 04:00, patient woke up at the middle of the night (as reported) with swollen face specially cheeks and eyes was swollen. Right (RT) cheek was more swollen than the left (LT) side. RT Eye was covered due to RT eye lid skin was dropping down to the point she cannot use it until the next day it retracted back (as reported). Patient still have swollen face, cheeks and eyes. RT eye and RT cheek was more swollen and felt very uncomfortable to wear a mask specially N95. The patient recovered with lasting effects. It was reported that treatment received for events (also reported that no treatment). Prior to vaccination, the patient was not diagnosed with COVID-19, and since the vaccination, she has been tested for COVID-19. Nasal Swab: unknown results on 22Feb2021 (COVID test post vaccination), negative on 02Mar2021. Outcome of all events was recovered with sequelae. No follow-up attempts are needed. No further information is expected.

Other Meds:

Current Illness:

ID: 1692587
Sex: F
Age:
State: LA

Vax Date: 02/01/2021
Onset Date:
Rec V Date: 09/11/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 037K20A
Dose Series: 1
Vax Route: IM
Vax Site: RA

Lab Data:

Allergies:

Symptom List: Hot flush, Myalgia, Nausea, Tension headache

Symptoms: itch; Red at injection site; Bruising; skin was a little more rough and more leathery than normal; skin was a little more rough and more leathery than normal; This is a spontaneous report from a contactable consumer (patient). A 78-year-old female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE Solution for injection), via an unspecified route of administration, on 01Feb2021 14:40 (Batch/lot number: EL9265), at age 78 years old, as dose 2, single, for COVID-19 immunisation, at a hospital. Relevant medical history and concomitant medications were not reported. Historical vaccine included BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE Solution for injection), received on 11Jan2021 (Batch/lot number: ELO142), at 78 years old, as dose 1 single, for COVID-19 immunisation after which the patient experienced rash at injection site, bruise, vaccination site pruritus, vaccination site erythema, vaccination site swelling and her skin was a little more rough and more leathery than normal. On an unspecified date, after the second vaccination, the patient experienced itch, red at injection site, bruising and her skin was a little more rough and more leathery than normal. The patient received an unspecified flu vaccine in Sep2021. No treatment was received for events itch, bruising, and skin was a little more rough and more leathery than normal. The outcome of bruising was not recovered. The outcome of the remaining events was unknown. No follow-up attempts are possible. No further information is expected.

Other Meds:

Current Illness:

Total 2021 VAERS Injuries: 654,986

Page last modified: 13 November 2021 9:17am